Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
淀粉样变性
淀粉样蛋白（真菌学）
作者
Mathew S. Maurer,Jeffrey H. Schwartz,Balarama Gundapaneni,Perry Elliott,Giampaolo Merlini,Márcia Waddington-Cruz,Arnt V. Kristen,Martha Grogan,Ronald Witteles,Thibaud Damy,Brian Drachman,Sanjiv J. Shah,Mazen Hanna,Daniel P. Judge,Alexandra I. Barsdorf,Peter M. Huber,Terrell A. Patterson,Steven Riley,Jennifer Schumacher,Michelle Stewart,Marla B. Sultan,Claudio Rapezzi
Transthyretin amyloid cardiomyopathy is caused by the deposition of transthyretin amyloid fibrils in the myocardium. The deposition occurs when wild-type or variant transthyretin becomes unstable and misfolds. Tafamidis binds to transthyretin, preventing tetramer dissociation and amyloidogenesis.
PDF的下载单位、IP信息已删除
浮游
Criminology34
zsyhcl
GingerF
6666
维奈克拉
映城
伊祁夜明
Luna
ho
tuanheqi
apiaji
ZJX
每天100次
小明
念柏
ccm
dabriaolga
lalala
香蕉觅云
皖公网安备34019202002308
